The role of cannabis-based medicinal products (CBMPs) in managing osteoarthritis symptoms: a scoping review of current evidence and future directions.
| Journal | Clinical rheumatology |
| Study Type | Clinical Study |
| Population | Human participants |
This item covers developments relevant to cannabis medicine and clinical practice. Clinicians monitoring evidence in this area should review the source material.
This review critically evaluates the therapeutic role of cannabis and its derivatives in managing osteoarthritic pain, with a focus on clinical evidence and efficacy of various pharmacological dose and forms. A literature search was conducted using Medline, EMBASE, CINAHL and COCHRANE databases with the key terms “cannabis”, “cannabidiol”, “CBD”, “osteoarthritis” and “human”. Inclusion criteria were limited to studies published in English with full-text access from year 2020 onwards; animal-based laboratory research, narrative surveys, and questionnaire-based studies were excluded. Out of 517 search results, 19 were included in this review. Initial clinical studies using different CBD formulations and dosages suggest potential benefits for relieving OA symptoms, with topical CBD showing the most encouraging results and an acceptable safety profile. Nonetheless, the overall strength of the evidence is constrained by considerable variability in CBD dosing and product types, as well as th
“This is a development worth tracking. The clinical implications will become clearer as more evidence accumulates.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
Can CBD help relieve osteoarthritis symptoms?
Early evidence suggests it might. According to this review, initial clinical studies using different CBD formulations and dosages suggest potential benefits for relieving osteoarthritis symptoms. However, the overall strength of the evidence is constrained by considerable variability in CBD dosing and product types, so these findings point to possible benefit rather than established effectiveness.
Which form of CBD looked most promising for osteoarthritis?
Topical CBD showed the most encouraging results among the forms studied, along with an acceptable safety profile. The review drew this from initial clinical studies that used a range of CBD formulations and dosages, so the comparison between forms is still preliminary.
How did the researchers select studies for this osteoarthritis review?
They searched Medline, EMBASE, CINAHL and Cochrane databases using terms including cannabis, cannabidiol, CBD, osteoarthritis and human. Inclusion was limited to English-language studies with full-text access published from 2020 onward, and animal-based laboratory research, narrative surveys, and questionnaire-based studies were excluded. Of 517 search results, 19 were included.
Get the next evidence review in your inbox
Plain-language summaries of the newest cannabis research, written by a physician. Free to read, and you can unsubscribe at any time.
Join the growing cannabis community. Free. One-click subscribe. Delivered by Substack.
